STOCK TITAN
  1. Home
  2. Sec-filings
  3. HIMS
  4. [Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Hims & Hers Health (HIMS) COO details RSU vesting and tax share withholding

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Hims & Hers Health, Inc. Chief Operating Officer Michael Chi reported equity compensation activity involving the company’s Class A common stock on December 15, 2025. He acquired 72,106 shares through the vesting and settlement of previously granted restricted stock units, increasing his direct holdings before tax withholding.

To cover related tax obligations, 39,870 shares were withheld by the company at a price of $36.25 per share. After these transactions, Chi directly beneficially owned 318,911 shares of Class A common stock. Multiple restricted stock unit awards continue to vest on a quarterly schedule over four-year service-based periods, with different grants beginning vesting on various Company Quarterly Vesting Dates from June 15, 2022 through June 15, 2025.

Positive

  • None.

Negative

  • None.
Insider Chi Michael
Role Chief Operating Officer
Type Security Shares Price Value
Exercise Restricted Stock Unit 9,356 $0.00 --
Exercise Restricted Stock Unit 16,496 $0.00 --
Exercise Restricted Stock Unit 16,297 $0.00 --
Exercise Restricted Stock Unit 19,358 $0.00 --
Exercise Restricted Stock Unit 10,599 $0.00 --
Exercise Class A Common Stock 72,106 $0.00 --
Tax Withholding Class A Common Stock 39,870 $36.25 $1.45M
Holdings After Transaction: Restricted Stock Unit — 9,357 shares (Direct); Class A Common Stock — 358,781 shares (Direct)
Footnotes (1)
  1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after December 15, 2022. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chi Michael
(Last) (First) (Middle)
2269 CHESTNUT STREET, #523
(Street)
SAN FRANCISCO CA 94123
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 12/15/2025 M 72,106 A (1) 358,781 D
Class A Common Stock 12/15/2025 F 39,870(2) D $36.25 318,911 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (1) 12/15/2025 M 9,356 (3) (3) Class A Common Stock 9,356 $0 9,357 D
Restricted Stock Unit (1) 12/15/2025 M 16,496 (4) (4) Class A Common Stock 16,496 $0 49,487 D
Restricted Stock Unit (1) 12/15/2025 M 16,297 (5) (5) Class A Common Stock 16,297 $0 81,487 D
Restricted Stock Unit (1) 12/15/2025 M 19,358 (6) (6) Class A Common Stock 19,358 $0 174,226 D
Restricted Stock Unit (1) 12/15/2025 M 10,599 (7) (7) Class A Common Stock 10,599 $0 137,790 D
Explanation of Responses:
1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
2. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.
3. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.
4. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after December 15, 2022.
5. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023.
6. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.
7. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.
Remarks:
/s/ Kimberly Mather, Attorney-in-Fact for Michael Chi 12/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did the Hims & Hers Health (HIMS) COO report?

Chief Operating Officer Michael Chi reported equity compensation activity on December 15, 2025, including the vesting and settlement of restricted stock units into Class A Common Stock and related share withholding for taxes.

How many HIMS shares did the COO acquire through RSU vesting?

On December 15, 2025, Michael Chi acquired 72,106 shares of Hims & Hers Health, Inc. Class A common stock, reported with transaction code M, reflecting the settlement of restricted stock units.

How many Hims & Hers Health shares were withheld for taxes and at what price?

The company withheld 39,870 shares of Class A common stock to cover tax withholding obligations in connection with the RSU vesting, at a reported price of $36.25 per share, noted with transaction code F.

What is the COO’s resulting ownership in Hims & Hers Health Class A common stock?

Following the December 15, 2025 transactions, Chief Operating Officer Michael Chi beneficially owned 318,911 shares of Hims & Hers Health, Inc. Class A common stock in direct form.

How do the Hims & Hers Health RSUs reported by the COO vest over time?

The reported restricted stock units are subject to service-based vesting over four-year periods, in substantially equal quarterly installments on each Company Quarterly Vesting Date. Different grants begin vesting on dates including June 15, 2022, December 15, 2022, June 15, 2023, June 15, 2024, and June 15, 2025.

What does each restricted stock unit (RSU) for Hims & Hers Health represent?

Each restricted stock unit reported by Michael Chi represents a contingent right to receive one share of Hims & Hers Health, Inc. Class A common stock upon vesting and settlement.